Active Ingredient: NICARDIPINE HYDROCHLORIDE
Proprietary Name: NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 20MG/200ML (0.1MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A215592
Product Number: 001
Approval Date: Sep 24, 2024
Applicant Holder Full Name: CIPLA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information